Skip to main content
Occupational and Environmental Medicine logoLink to Occupational and Environmental Medicine
. 1997 Oct;54(10):702–707. doi: 10.1136/oem.54.10.702

Mortality of workers exposed to dieldrin and aldrin: a retrospective cohort study.

G de Jong 1, G M Swaen 1, J J Slangen 1
PMCID: PMC1128923  PMID: 9404316

Abstract

OBJECTIVE: To investigate the occurrence of long term health effects in humans exposed to aldrin and dieldrin, with an update of an earlier retrospective cohort mortality study. METHODS: A group of 570 workers employed between 1 January 1954 and 1 January 1970 either in a production or formulation plant were followed up for mortality until 1 January 1993. There were extensive industrial hygiene data available and biological monitoring data of aldrin and dieldrin for most of the workers. From these data individual estimates were made of the total intake of dieldrin. A total number of 2539.37 person-years at risk was added to the original study. RESULTS: 118 deaths were observed compared with 156 expected. No increase in mortality from liver cancer was found. However, there was an excess in mortality from rectal cancer. This excess was inversely related to the dose gradient. An analysis by job title did not show any excess cancer in any particular job. CONCLUSION: The study does not support a carcinogenic effect of dieldrin and aldrin in humans.

Full text

PDF
702

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amoateng-Adjepong Y., Sathiakumar N., Delzell E., Cole P. Mortality among workers at a pesticide manufacturing plant. J Occup Environ Med. 1995 Apr;37(4):471–478. doi: 10.1097/00043764-199504000-00020. [DOI] [PubMed] [Google Scholar]
  2. Brown D. P. Mortality of workers employed at organochlorine pesticide manufacturing plants--an update. Scand J Work Environ Health. 1992 Jun;18(3):155–161. doi: 10.5271/sjweh.1593. [DOI] [PubMed] [Google Scholar]
  3. Hunter C. G., Robinson J. Pharmacodynamics of dieldrin (HEOD). I. Ingestion by human subjects for 18 months. Arch Environ Health. 1967 Nov;15(5):614–626. doi: 10.1080/00039896.1967.10664977. [DOI] [PubMed] [Google Scholar]
  4. Hunter C. G., Robinson J., Roberts M. Pharmacodynamics of dieldrin (HEOD). Ingestion by human subjects for 18 to 24 months, and postexposure for eight months. Arch Environ Health. 1969 Jan;18(1):12–21. doi: 10.1080/00039896.1969.10665367. [DOI] [PubMed] [Google Scholar]
  5. Ulm K. A simple method to calculate the confidence interval of a standardized mortality ratio (SMR) Am J Epidemiol. 1990 Feb;131(2):373–375. doi: 10.1093/oxfordjournals.aje.a115507. [DOI] [PubMed] [Google Scholar]
  6. Walker A. I., Stevenson D. E., Robinson J., Thorpe E., Roberts M. The toxicology and pharmacodynamics of dieldrin (HEOD): two-year oral exposures of rats and dogs. Toxicol Appl Pharmacol. 1969 Sep;15(2):345–373. doi: 10.1016/0041-008x(69)90034-9. [DOI] [PubMed] [Google Scholar]

Articles from Occupational and Environmental Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES